Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice

A Svilaas1, K Risberg, M Thoresen

  • 1Lipid Clinic, Medical Department, Rikshospitalet, Oslo, Norway. asvilaas@online.no

Insights

Statin drug treatment is not fully accepted by Norwegian physicians, who also do not titrate medications to target goals. This impacts patient care and cardiovascular outcomes.

Area of Science:

  • Cardiovascular medicine
  • Pharmacology

Background:

  • Statin therapy is crucial for managing hyperlipidemia and preventing cardiovascular events.
  • Physician adherence to treatment guidelines, including statin titration, is essential for optimal patient outcomes.

Purpose of the Study:

  • To assess the level of acceptance and utilization of statin drug treatment among physicians in Norway.
  • To evaluate the extent to which physicians in Norway titrate statin therapy to recommended target goals.

Main Methods:

  • The study likely involved a survey or analysis of prescribing data from Norwegian physicians.
  • Data collection focused on physician attitudes towards statins and their prescribing practices regarding titration.

Main Results:

  • Statin drug treatment has not achieved complete acceptance among Norwegian physicians.
  • Physicians in Norway are not consistently titrating statin therapy to recommended target goals.

Conclusions:

  • There are significant gaps in the acceptance and application of evidence-based statin treatment protocols in Norway.
  • Interventions are needed to improve physician understanding and implementation of statin titration for better cardiovascular risk management.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...